Sullivan Timothy Eugene (CIK 0001707000)

Latest company ownership

APLS - Apellis Pharmaceuticals, Inc.

Role: CFO

Shares held

60,396

Last filed at

Oct 23, 2025

Confidence Score

31.4

2025Q4

Confidence Score History

2019Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 21, 2025	Oct 23, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	30.0	-10,000	-5.51%	✓	$280.3K
Sep 8, 2025	Sep 10, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	15.0	-42,729	-19.96%	✓	$1.2M
Jan 29, 2025	Jan 30, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	51.3	-546	-0.27%	✗	$16.1K
Jan 22, 2025	Jan 23, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	42.5	-3,088	-1.52%	✗	$94K
Jan 17, 2025	Jan 21, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	95.0	+44,199	27.89%	✗	$51.8K
Jan 13, 2025	Jan 14, 2025	Apellis Pharmaceuticals, Inc.	CFO	Sell	42.5	-2,170	-1.35%	✗	$62.3K
Apr 1, 2024	Apr 2, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	41.3	-4,000	-2.60%	✓	$234.6K
Mar 1, 2024	Mar 5, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	35.0	-6,000	-3.86%	✓	$379.3K
Feb 12, 2024	Feb 13, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	45.0	-1,431	-0.95%	✗	$97K
Jan 29, 2024	Jan 31, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	45.0	-906	-0.60%	✗	$58.1K
Jan 22, 2024	Jan 23, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	42.5	-3,551	-2.28%	✗	$230.8K
Jan 16, 2024	Jan 17, 2024	Apellis Pharmaceuticals, Inc.	CFO	Sell	95.0	+21,513	16.06%	✗	$149.3K
Nov 30, 2023	Dec 1, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	26.3	-14,158	-9.56%	✓	$774.9K
Jul 3, 2023	Jul 6, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	35.0	-6,779	-4.82%	✓	$609.9K
Jun 5, 2023	Jun 6, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	3.8	-69,779	-34.25%	✓	$6.2M
Feb 21, 2023	Feb 22, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	90.0	+10,709	8.69%	✗	$57K
Feb 10, 2023	Feb 14, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	36.3	-975	-0.78%	✗	$49.9K
Jan 27, 2023	Jan 30, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	43.8	-551	-0.44%	✗	$29.1K
Jan 20, 2023	Jan 24, 2023	Apellis Pharmaceuticals, Inc.	CFO	Sell	22.5	-2,379	-1.87%	✗	$123.8K
Feb 10, 2022	Feb 14, 2022	Apellis Pharmaceuticals, Inc.	CFO	Sell	48.8	-875	-0.84%	✗	$41.2K
Jan 28, 2022	Feb 1, 2022	Apellis Pharmaceuticals, Inc.	CFO	Sell	48.8	-650	-0.62%	✗	$25.1K
Feb 10, 2021	Feb 11, 2021	Apellis Pharmaceuticals, Inc.	CFO	Sell	26.3	-858	-2.44%	✗	$40.9K
Aug 29, 2019	Sep 3, 2019	Apellis Pharmaceuticals, Inc.	CFO	Buy	97.5	+11,699	100.00%	✓	$347.6K